4-(methoxymethyl)cyclohex-1-ene | 145827-26-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(methoxymethyl)cyclohex-1-ene
• 英文别名: 4-(methoxymethyl)cyclohexene；cyclohex-3-enylmethyl-methyl ether；Cyclohex-3-enylmethyl-methyl-aether；(+/-)-1-Methoxymethyl-cyclohexen-(3)
• CAS: 145827-26-5
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: BFEFPVJJJCFYPU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-(methoxymethyl)cyclohex-1-ene 在 二丁醚 disodium hydrogenphosphate 、 双氧水 、 六氟丙酮 作用下， 以 various solvent(s) 为溶剂， 反应 20.0h， 以89%的产率得到吡咯烷,1-(2-哌嗪基羰基)-(9CI)
  参考文献：
  名称：

  Hexafluoro-2-propanol 中的 Hexafluoroacetone：一种用于过氧化氢水溶液环氧化的高活性介质

  摘要：

  将六氟-2-丙醇和催化剂量的六氟丙酮结合在一起，可提供一种多功能介质，用于多种烯烃与过氧化氢水溶液的环氧化反应。

  DOI：

  10.1055/s-2001-16037
• 作为产物：
  描述：

  3-环己烯-1-甲醇 在 NaH 、 碘甲烷 作用下， 以 四氢呋喃 为溶剂， 生成 4-(methoxymethyl)cyclohex-1-ene
  参考文献：
  名称：

  ALTERNATING RING-OPENING METATHESIS POLYMERIZATION

  摘要：

  这项发明涉及聚合物和烯烃聚合领域，更具体地涉及烯烃交换聚合。该发明提供了规则交替聚合物和合成这种聚合物的方法。

  公开号：

  US20110212046A1

文献信息

• Piperazine Compounds with Herbicidal Effect
  申请人：Parra Rapado Liliana

  公开号：US20110130286A1

  公开（公告）日：2011-06-02

  Piperazine compounds of the formula I in which the variables are defined according to the description, their agriculturally suitable salts, processes and intermediates for preparing the piperazine compounds of the formula I, compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidally effective amount of at least one piperazine compound of the formula I to act on plants, their seed and/or their habitat.

  化学式I中变量根据描述定义的哌嗪化合物，其在农业上适用的盐，制备化学式I中哌嗪化合物的过程和中间体，包含它们的组合物以及它们作为除草剂的用途，即用于控制有害植物，还包括一种控制不良植被的方法，其中包括让至少一种化学式I中的哌嗪化合物对植物、它们的种子和/或它们的栖息地产生除草作用的有效量。
• (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS
  申请人：Iwema Bakker Wouter I.

  公开号：US20120220552A1

  公开（公告）日：2012-08-30

  The present disclosure relates to (thio)morpholine derivatives of the formula (I) wherein R1 is selected from cyano, (2-4C)alkynyl, (1-4C)alkyl, (3-6C)cycloalkyl, (4-6C)cycloalkenyl, (6-8C)bicycloalkyl, (8-10C)bicyclic group, each optionally substituted with (1-4C)alkyl, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (2-4C)alkynyl, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, amino, di(1-4C)alkylamino, —SO 2 -(1-4C)alkyl, —CO-(1-4C)alkyl, —CO—O-(1-4C)alkyl, —NH—CO-(1-4C)alkyl and (3-6C)cycloalkyl, phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4C)alkyl, monocyclic heterocycle optionally substituted with halogen, (1-4C)alkyl or with phenyl optionally substituted with (1-4C)alkyl, and bicyclic heterocycle optionally substituted with (1-4C)alkyl; A is selected from —CO—O—, —O—CO—, —NH—CO—, —CO—NH, —C═C—, —CCH 3 —O— and the linking group —Y—(CH 2 ) n —X— wherein Y is attached to R1 and selected from a bond, —O—, —S—, —SO—, —SO 2 —, —CH 2 —O—, —CO—, —O—CO—, —CO—O—, —CO—NH—, —NH—CO—, —C═C— and —C≡C—; n is an integer from 1 to 10; and X is attached to the phenylene/pyridyl group and selected from a bond, —O—, —S—, —SO—, —SO 2 —, —NH, —CO—, —C═C— and —C≡C—; ring structure B optionally contains one nitrogen atom; R2 is H, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and R3 is (1-4C)alkylene-R5 wherein the alkylene group may be substituted with (CH 2 ) 2 to form a cyclopropyl moiety or one or two halogen atoms, or R3 is (3-6C)cycloalkylene-R5 or —CO—CH 2 —R5, wherein R5 is —OH, —PO 3 H 2 , —OPO 3 H 2 , —COOH, —COO(1-4C)alkyl or tetrazol-5-yl; R4 is H or (1-4C)alkyl; R6 is one or more substituents independently selected from H, (1-4C)alkyl or oxo; W is —O—, —S—, —SO— or —SO 2 —; or a pharmaceutically acceptable salt, a solvate or hydrate thereof; with the proviso that the derivative of formula (I) is not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile or a pharmaceutically acceptable salt, a solvate or hydrate thereof. The compounds of the disclosure have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of S1P receptor mediated diseases and conditions.

  本公开涉及以下式子的(硫)吗啡啶衍生物(I)： 其中，R1从氰基，(2-4C)炔基，(1-4C)烷基，(3-6C)环烷基，(4-6C)环烯基，(6-8C)双环烷基，(8-10C)双环基中选择，每个基都可以选择性地被(1-4C)烷基，苯基，联苯基，萘基取代，每个基也可以选择性地被一个或多个取代基独立地选择，所述取代基包括卤素，(1-4C)烷基可选择地被一个或多个氟原子取代，(2-4C)炔基，(1-4C)烷氧基可选择性地被一个或多个氟原子取代，氨基，二(1-4C)烷基氨基，—SO2-(1-4C)烷基，—CO-(1-4C)烷基，—CO—O-(1-4C)烷基，—NH—CO-(1-4C)烷基和(3-6C)环烷基，苯基取代为苯氧基，苄基，苄氧基，苯乙基或单环杂环，每个基都可以选择性地被(1-4C)烷基取代，单环杂环可选择性地被卤素，(1-4C)烷基或苯基取代，或双环杂环可选择性地被(1-4C)烷基取代； A从—CO—O—，—O—CO—，—NH—CO—，—CO—NH，—C═C—，—CCH3—O—和连接基—Y—(CH2)n—X—中选择，其中Y连接到R1并从键，—O—，—S—，—SO—，—SO2—，—CH2—O—，—CO—，—O—CO—，—CO—O—，—CO—NH—，—NH—CO—，—C═C—和—C≡C—中选择；n是1到10的整数；X连接到苯基/吡啶基并从键，—O—，—S—，—SO—，—SO2—，—NH，—CO—，—C═C—和—C≡C—中选择；环结构B可选择性地包含一个氮原子； R2为H，(1-4C)烷基可选择性地被一个或多个氟原子取代，(1-4C)烷氧基可选择性地被一个或多个氟原子取代，或卤素； R3为(1-4C)烷基-R5，其中烷基可以被(CH2)2取代以形成环丙基基团或一或两个卤素原子，或R3为(3-6C)环烷基-R5或—CO—CH2—R5，其中R5为—OH，—PO3H2，—OPO3H2，—COOH，—COO(1-4C)烷基或四唑-5-基； R4为H或(1-4C)烷基； R6为一个或多个取代基，独立地选择自H，(1-4C)烷基或氧代基； W为—O—，—S—，—SO—或—SO2—； 或其药学上可接受的盐、溶剂或水合物； 但是，公开的衍生物式(I)不包括2-(4-乙基苯基)-4-吗啡啶基乙醇或4-[4-(2-羟乙基)-2-吗啡啶基]苯乙腈或其药学上可接受的盐、溶剂或水合物。 本公开的化合物具有对S1P受体的亲和力，并可用于治疗、缓解或预防S1P受体介导的疾病和症状。
• Alternating ring-opening metathesis polymerization
  申请人：Sampson Nicole

  公开号：US08795647B2

  公开（公告）日：2014-08-05

  The invention relates to the field of polymers and olefin polymerization, and more specifically olefin metathesis polymerization. The invention provides regioregular alternating polymers and methods of synthesizing such polymers.

  本发明涉及聚合物和烯烃聚合领域，更具体地涉及烯烃交换聚合。本发明提供了规则交替的聚合物和合成这种聚合物的方法。
• Metathesis polymerization adhesives and coatings
  申请人：Lord Corporation

  公开号：US20030058812A1

  公开（公告）日：2003-03-27

  An adhesive or coating composition prepared by mixing together at least one metathesizable highly-reactive cycloolefin (e.g., a norbornadiene) and a metathesis catalyst. The use of highly-reactive cycloolefins can provide exceptional adherence to a low-surface-tension substrate. Another embodiment is a two-part adhesive or coating system wherein the first part includes at least one first metathesizable material, and the second part includes at least one liquid metathesis oligomer or polymer and a metathesis catalyst.

  将至少一种可偏析的高活性环烯烃（如降冰片二烯）和偏析催化剂混合在一起制备的粘合剂或涂料组合物。使用高活性环烯烃可为低表面张力基材提供优异的附着力。另一个实施方案是一种双组分粘合剂或涂层系统，其中第一部分包括至少一种第一元气化材料，第二部分包括至少一种液态元气化低聚物或聚合物和一种元气化催化剂。
• 76. Alicyclic glycols. Part III. 4-Hydroxymethylcyclohexanol
  作者：L. N. Owen、P. A. Robins

  DOI：10.1039/jr9490000326

  日期：——